HealthWise KnowledgeBase
Aromatase Inhibitors for Breast Cancer
How Well It Works
Aromatase inhibitors make it less likely that breast cancer will come back. These medicines work well for postmenopausal women who have had ER+ breast cancer. Studies that compare survival rates for aromatase inhibitors and tamoxifen show that women live about the same length of time when taking either of these medicines.Reference 2
Aromatase inhibitors may be given to postmenopausal women who have breast cancer, either at the beginning of treatment or after they are given tamoxifen.
| By: | Reference Healthwise Staff | Last Revised: August 11, 2011 |
| Medical Review: | Reference Sarah Marshall, MD - Family Medicine
Reference Douglas A. Stewart, MD - Medical Oncology |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
